47
Participants
Start Date
May 23, 2023
Primary Completion Date
May 31, 2026
Study Completion Date
May 31, 2026
PYX-106
Intravenous (IV) infusion
Cliniques Universitaires Saint-Luc, Brussels
Universitair Ziekenhuis Leuven - Campus Gasthuisberg, Leuven
Grand Hôpital de Charleroi - Notre Dame, Charleroi
Universitair Ziekenhuis Gent, Ghent
NEXT Virginia, Fairfax
START Madrid - Hospital Universitario Fundación Jiménez Díaz, Madrid
Hospital Universitario 12 de Octubre, Madrid
HM Centro Integral Oncológico Clara Campal, Madrid
Winship Cancer Institute of Emory University, Atlanta
Gabrail Cancer and Research Center, Canton
Hospital Clínico Universitario de Valencia, Valencia
University of Chicago Medicine, Chicago
NEXT Oncology, Irving
SCRI- HealthOne Denver, Denver
HonorHealth Research Institute, Scottsdale
University of Southern California, Los Angeles
University of California San Diego, La Jolla
Dana-Farber Cancer Institute, Boston
Lifespan - Rhode Island Hospital, Providence
Hospital Universitari Dexeus, Barcelona
Pyxis Oncology, Inc
INDUSTRY